These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 2486767)

  • 21. Prazosin GITS vs sustained release nifedipine in patients with hypertension and abnormal lipid profile: a randomized, controlled, multicenter study. Madras Hypertension Study Group.
    Misra KP; Joglekar SJ; Mukherjee S; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():30-40. PubMed ID: 11233385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concomitant administration of terazosin and atenolol for the treatment of essential hypertension.
    Holtzman JL; Kaihlanen PM; Rider JA; Lewin AJ; Spindler JS; Oberlin JA
    Arch Intern Med; 1988 Mar; 148(3):539-43. PubMed ID: 3277569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prazosin GITS vs atenolol in patients with hypertension and normal lipid profile: a randomized, controlled multicenter study. Hyderabad Hypertension Study Group.
    Joglekar SJ; Jaguste V; Nanivadekar AS
    J Assoc Physicians India; 1998; Suppl 1():41-51. PubMed ID: 11233386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nadolol antihypertensive effect and disposition in young and elderly adults with mild to moderate essential hypertension.
    Mitenko PA; McKenzie JK; Sitar DS; Penner SB; Aoki FY
    Clin Pharmacol Ther; 1989 Jul; 46(1):56-62. PubMed ID: 2663317
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential exercise effects of captopril and nadolol in patients with essential hypertension.
    Kostis JB; Shindler DM; Moreyra AE; Ruddy MC; Schneider S; Cosgrove N
    Angiology; 1992 Aug; 43(8):647-52. PubMed ID: 1632567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Role of a beta adrenergic blocking agent nadolol (corgard) in prevention of arterial hypertension: a 6-month treatment (cooperative study)].
    Metelitsa VI; Filatova NP
    Kardiologiia; 1990 May; 30(5):8-14. PubMed ID: 2202853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of nadolol on hemodynamic and hemostatic responses to potential mental and physical triggers of myocardial infarction in subjects with mild systemic hypertension.
    Jimenez AH; Tofler GH; Chen X; Stubbs ME; Solomon HS; Muller JE
    Am J Cardiol; 1993 Jul; 72(1):47-52. PubMed ID: 8517427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The pharmacokinetics and pharmacodynamics of the prolonged-action beta-adrenoblocker nadolol at rest after a single administration to hypertension patients].
    Poteshnykh AV; Filatova NP; Metelitsa VI; Piotrovskiĭ VK; Malysheva NV; Ignat'ev AIu
    Eksp Klin Farmakol; 1992; 55(5):25-8. PubMed ID: 1305446
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of nadolol on heart rate in hyperthyroidism. A controlled trial.
    Lazarus JH; Kingswood JC; John R
    Acta Endocrinol (Copenh); 1987 Jan; 114(1):102-6. PubMed ID: 3544631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of twice daily nadolol on intraocular pressure.
    Duff GR
    Am J Ophthalmol; 1987 Oct; 104(4):343-5. PubMed ID: 3661642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of nadolol in a clinic population of migrainous patients.
    Medina JL
    Headache; 1988 Mar; 28(2):99-102. PubMed ID: 3372246
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of nadolol on flushing reactions in rosacea.
    Wilkin JK
    J Am Acad Dermatol; 1989 Feb; 20(2 Pt 1):202-5. PubMed ID: 2521641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nigerian Population Research on Environment, Gene and Health (NIPREGH) - objectives and protocol.
    Odili AN; Ogedengbe JO; Nwegbu M; Anumah FO; Asala S; Staessen JA
    J Biomed Res; 2014 Sep; 28(5):360-7. PubMed ID: 25332707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FIRST REPORTS OF CLINICAL PHARMACOKINETICS IN NIGERIA.
    Michael OS
    Ann Ib Postgrad Med; 2015 Jun; 13(1):48-53. PubMed ID: 26807087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical experience with nadolol in Nigerian patients with essential hypertension.
    Iyun AO
    West Afr J Med; 1989; 8(1):18-28. PubMed ID: 2486767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Open study on the effect and side effects of indoramin, used at the 2d and 3d therapeutic step in essential hypertension].
    Hitzenberger G; Korn A
    Wien Med Wochenschr; 1985 Sep; 135(17):425-30. PubMed ID: 4060742
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.